Filing Details
- Accession Number:
- 0001237899-12-000090
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-30 13:47:31
- Reporting Period:
- 2012-11-28
- Filing Date:
- 2012-11-30
- Accepted Time:
- 2012-11-30 13:47:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1013064 | Roy P Vagelos | 777 Old Saw Mill River Road Tarrytown NY 10591 | Chairman Of The Board | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2012-11-28 | 7,004 | $175.03 | 135,576 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 1,800 | $175.95 | 133,776 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 5,100 | $176.54 | 128,676 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 4,402 | $177.09 | 124,274 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 18,440 | $178.71 | 105,834 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 19,733 | $179.60 | 86,101 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 12,000 | $180.59 | 74,101 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2012-11-29 | 17,155 | $181.19 | 56,946 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 82,410 | Indirect | by GRAT |
| Common Stock | 2,329 | Indirect | By 401(k) Plan |
| Common Stock | 162,657 | Indirect | by CLAT |
| Common Stock | 15,162 | Indirect | by GRAT |
| Common Stock | 3 | Indirect | by GRAT |
| Common Stock | 127,500 | Indirect | by Spouse as Trustee |
| Common Stock | 1,203 | Indirect | by trust for grandch |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 7,004 shares of Company stock on November 28, 2012 at prices ranging from $175.00 to $175.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 28, 2012 at each separate price.
- Represents volume-weighted average price of sales of 1,800 shares of Company stock on November 29, 2012 at prices ranging from $175.45 to $175.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 5,100 shares of Company stock on November 29, 2012 at prices ranging from $176.00 to $176.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 4,402 shares of Company stock on November 29, 2012 at prices ranging from $177.00 to $177.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 18,440 shares of Company stock on November 29, 2012 at prices ranging from $178.51 to $178.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 19,733 shares of Company stock on November 29, 2012 at prices ranging from $179.00 to $179.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 12,000 shares of Company stock on November 29, 2012 at prices ranging from $180.00 to $180.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- Represents volume-weighted average price of sales of 17,155 shares of Company stock on November 29, 2012 at prices ranging from $181.00 to $181.80. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 29, 2012 at each separate price.
- By an irrevocable trust for the benefit of grandchildren of the reporting person, of which the spouse of the reporting person is trustee.
- By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.
Billionaire Hedge Funds
